| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |